Clinical research studies at the Diabetes Research Institute offer participants the opportunity to play a more active role in their own healthcare.
Patients involved in clinical “trials” can also access potential new treatments before they are widely available. These studies provide important information to advance medical care and are crucial to finding a definitive cure for diabetes.
After a promising new treatment is developed in the laboratory and its safety and effectiveness is carefully tested in the pre-clinical setting, clinical investigators obtain Institutional Review Board (IRB) approval to conduct studies in patients.
Participants receive high-quality care and related study medications throughout the trial at no cost. Participating in a clinical trial is an important personal decision.
For information on DRI trials, please explore the sections below.
The DRI is currently conducting a number of clinical islet transplant trials for select patients
with type 1 diabetes.
|
|
Studies are currently underway to help better understand the causes of diabetes and to develop strategies to prevent its onset. |
|
DRI offers ongoing clinical trials with investigational medications. |
|
|
For general information about clinical trials, please click here.